Filgrastim
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00099 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 69 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | Scott syndrome | KG + DL |
| 5 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 6 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 7 | C1 inhibitor deficiency | KG + DL |
| 8 | serpinopathy with toxic serpin polymerization | KG + DL |
| 9 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 10 | platelet-type bleeding disorder | KG + DL |
| 11 | hereditary angioedema with C1Inh deficiency | KG + DL |
| 12 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 13 | Peyronie disease | KG + DL |
| 14 | primary immunodeficiency syndrome due to p14 deficiency | KG + DL |
| 15 | mixed-type autoimmune hemolytic anemia | KG + DL |
| 16 | proteinuria | KG + DL |
| 17 | primary CD59 deficiency | KG + DL |
| 18 | drug-induced autoimmune hemolytic anemia | KG + DL |
| 19 | paroxysmal nocturnal hemoglobinuria | KG + DL |
| 20 | neonatal autoimmune hemolytic anemia | KG + DL |
| 21 | flood factor deficiency | KG + DL |
| 22 | cold agglutinin disease | KG + DL |
| 23 | biotin metabolic disease | KG + DL |
| 24 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 25 | familial thrombomodulin anomalies | KG + DL |
| 26 | inherited thrombophilia | KG + DL |
| 27 | X-linked severe congenital neutropenia | KG + DL |
| 28 | Barth syndrome | KG + DL |
| 29 | methylcobalamin deficiency type cblG | KG + DL |
| 30 | autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | KG + DL |
| 31 | autosomal recessive severe congenital neutropenia due to CSF3R deficiency | KG + DL |
| 32 | autosomal recessive severe congenital neutropenia due to CXCR2 deficiency | KG + DL |
| 33 | adult idiopathic neutropenia | KG + DL |
| 34 | congenital neutropenia-myelofibrosis-nephromegaly syndrome | KG + DL |
| 35 | cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder | KG + DL |
| 36 | vitamin deficiency disorder | KG + DL |
| 37 | autosomal recessive severe congenital neutropenia due to G6PC3 deficiency | KG + DL |
| 38 | autoimmune thrombocytopenic | KG + DL |
| 39 | inborn error of biotin metabolism | KG + DL |
| 40 | primary hyperoxaluria | KG + DL |
| 41 | Evans syndrome | KG + DL |
| 42 | congenital factor V deficiency | KG + DL |
| 43 | thrombotic thrombocytopenic purpura | KG + DL |
| 44 | constitutional megaloblastic anemia due to folate metabolism disorder | KG + DL |
| 45 | neonatal thrombocytopenia | KG + DL |
| 46 | inborn disorder of pyridoxine metabolism | KG + DL |
| 47 | cerebral folate deficiency | KG + DL |
| 48 | small bowel Crohn disease | KG + DL |
| 49 | Kostmann syndrome | KG + DL |
| 50 | glaucoma | KG + DL |
(Showing top 50 of 69 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.